0001209191-20-050353.txt : 20200914
0001209191-20-050353.hdr.sgml : 20200914
20200914204312
ACCESSION NUMBER: 0001209191-20-050353
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200914
DATE AS OF CHANGE: 20200914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEHRENS M KATHLEEN
CENTRAL INDEX KEY: 0001211701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39045
FILM NUMBER: 201174498
MAIL ADDRESS:
STREET 1: 6701 KAISER DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IGM Biosciences, Inc.
CENTRAL INDEX KEY: 0001496323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770349194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-965-7873
MAIL ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
FORMER COMPANY:
FORMER CONFORMED NAME: Palingen, Inc.
DATE OF NAME CHANGE: 20100712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-10
0
0001496323
IGM Biosciences, Inc.
IGMS
0001211701
BEHRENS M KATHLEEN
C/O IGM BIOSCIENCES, INC.
325 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2020-09-10
4
P
0
978
56.406
A
64192
D
Common Stock
2020-09-10
4
P
0
2367
57.7488
A
66559
D
Common Stock
2020-09-10
4
P
0
5132
58.7512
A
71691
D
Common Stock
2020-09-10
4
P
0
4442
59.646
A
76133
D
Common Stock
2020-09-10
4
P
0
5033
60.8648
A
81166
D
Common Stock
2020-09-10
4
P
0
4336
61.8044
A
85502
D
Common Stock
2020-09-10
4
P
0
2791
63.0611
A
88293
D
Common Stock
2020-09-10
4
P
0
3351
63.5762
A
91644
D
Common Stock
2020-09-10
4
P
0
1570
64.7955
A
93214
D
Common Stock
10000
I
See footnote
Common Stock
10000
I
See footnote
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $56.00 to $56.985 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $57.24 to $58.235 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $58.25 to $59.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $59.27 to $60.205 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $60.28 to $61.27 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $61.32 to $62.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $62.36 to $63.355 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $63.3625 to $64.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $64.475 to $65.245 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
/s/ Misbah Tahir, by power of attorney
2020-09-14